Follicum’s primary drug candidate has, in preclinical studies, been shown to inhibit hair growth very efficiently. In other preclinical models strong stimulation of hair growth has been observed. In both cases the effect has been observed at low doses, and no adverse effects have been seen.
- Bli medlem
- Om SwedenBIO